Meglumine iodipamide (Cholografin) hepatotoxicity.
Two cases of meglumine iodipamide (Cholografin) hepatotoxicity were confirmed by liver biopsy. The hepatic lesion was centrilobular in location and resolved within a short period of time. Nausea and vomiting commonly reported after intravenous cholangiography may be clinical manifestations of this entity.
D000328:Adult; D001706:Biopsy; D056486:Chemical and Drug Induced Liver Injury / Q000175:diagnosis / Q000209:etiology*; D002758:Cholangiography / Q000009:adverse effects; D005260:Female; D006801:Humans; D007458:Iodipamide / Q000009:adverse effects*; D008099:Liver / Q000473:pathology; D008297:Male; D008536:Meglumine / Q000009:adverse effects*; D013012:Sorbitol / Q000031:analogs & derivatives*
D013012:Sorbitol; D008536:Meglumine; D007458:Iodipamide